HbA1c screening for undiagnosed diabetes in New Zealand

Diabetes/Metabolism Research and Reviews

Volumn 21, Issue 1, 2005, Pages 65-70

  Ellison, Tracy L ^a,b   Elliott, Robert ^c   Moyes, Simon A ^c  

^a LEIGHTON HOSPITAL   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c Hepatitis Foundation   (New Zealand)

Author keywords

Diabetes; HbA1c; Maori; New Zealand; Screening

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIET RESTRICTION; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; GLUCOSE INTOLERANCE; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; INDIAN; MAJOR CLINICAL STUDY; MALE; MAORI; MASS SCREENING; NEW ZEALAND; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL GLUCOSE TOLERANCE TEST; PACIFIC ISLANDER; PRIORITY JOURNAL; RISK ASSESSMENT; SCREENING TEST; SENSITIVITY AND SPECIFICITY; VASCULAR DISEASE; DIABETES MELLITUS; METHODOLOGY; REPRODUCIBILITY;

DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; ETHNIC GROUPS; FEMALE; GLUCOSE INTOLERANCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MASS SCREENING; NEW ZEALAND; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 12844271221     PISSN: 15207552     EISSN: None     Source Type: Journal    
DOI: 10.1002/dmrr.486     Document Type: Article

References (29)

1. Screening for diabetes in asymptomatic individuals. New Zealand Society for the Study of Diabetes. N Z Med J 1995; 108 1011): 464-465.
2. Report of the Expert Committee on the Diagnosis and classification of diabetes mellitus. Diabetes Care 2002; 25 90001): S5-S20.
3. Barnett P, Beaven DW, Hegan K. Diabetes in New Zealand: too many, too late. N Z Med J 2001; 114(1145): 555-557.
4. Kenealy T, Braatvedt G, Scragg R. Screening for type 2 diabetes in non-pregnant adults in New Zealand: practice recommendations. N Z Med J 2002; 115(1152): 194-196.
5. Tuomilehto J, Lindstrom J, Eriksson JG. et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344 18): 1343-1350.
6. Uusitupa M, Louheranta A, Lindstrom J. et al. The Finnish Diabetes Prevention Study. Br J Nutr 2000; 83(Suppl. 1): S137-S142.
7. Adriaanase MC, Snoek FJ, Dekker JM, Ploeg HMV, Heine RJ. Screening for Type 2 diabetes: an exploration of subjects' perceptions regarding diagnosis and procedure. Diabet Med 2002; 19(5): 406-411.
8. Alberti K, Zimmet P. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. World Health Organisation, Dept of noncommunicable disease surveillance: Geneva, 1999.
9. McCance DR, Hanson RL, Charles MA. et al. Comparison of tests for glycated haemoglobin and fasting and two hour plasma glucose concentrations as diagnostic methods for diabetes. BMJ 1994; 308 6940): 1323-1328.
10. Peters AL, Davidson MB, Schriger DL, Hasselblad V. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels. A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. JAMA 1996; 276(15): 1246-1252.
11. 1c) in screening for undiagnosed diabetes in the U.S. population. Diabetes Care 2000; 23(2): 187-191.
12. Sacks DB, Bruns DE, Goldstein DE, Maclaren NK, McDonald JM, Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002; 48(3): 436-472.
13. Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001; 47(11): 1985-1992.
14. Khaw KT, Wareham N, Luben R. et al. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). BMJ 2001; 322(7277): 15-18.
15. Beks PJ, Mackaay AJ, de Neeling JN, de Vries H, Bouter LM, Heine RJ. Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: the Hoorn study. Diabetologia 1995; 38(1): 86-96.
16. Papoz L, Favier F, Clabe A, Sanchez A, Le Moullec N. GHb (HbA(1c)) is more sensitive than fasting blood glucose as a screening test for diabetes. Diabetes Care 2000; 23(8): 1206-1207; discussion 1208.
17. Australasia RCoPo. Quality Assurance Programs; 2002.
18. Ollerton RL, Playle R, Ahmed K, Dunstan FD, Luzio SD, Owens DR. Day-to-day variability of fasting plasma glucose in newly diagnosed type 2 diabetic subjects. Diabetes Care 1999; 22(3): 394-398.
19. Mooy JM, Grootenhuis PA, de Vries H. et al. Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study. Diabetologia 1996; 39 3): 298-305.
20. Ko GT, Chan JC, Tsang LW, Cockram CS. Combined use of fasting plasma glucose and HbA1c predicts the progression to diabetes in Chinese subjects. Diabetes Care 2000; 23(12): 1770-1773.
21. Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care 2001; 24(3): 465-471.
22. Takahashi Y, Noda M, Tsugane S, Kuzuya T, Ito C, Kadowaki T. Prevalence of diabetes estimated by plasma glucose criteria combined with standardized measurement of HbA1c among health checkup participants on Miyako Island, Japan. Diabetes Care 2000; 23(8): 1092-1096.
23. Snehalatha C, Ramachandran A, Satyavani K, Vijay V. Limitations of glycosylated haemoglobin as an index of glucose intolerance. Diabetes Res Clin Pract 2000; 47(2): 129-133.
24. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 1987; 36: 523-534.
25. Simmons D, Harry T, Gatland B. Prevalence of known diabetes in different ethnic groups in inner urban South Auckland. N Z Med J 1999; 112: 316-319.
26. Olivarius NF, Beck-Nielsen H, Andreasen AH. et al. Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ 2001; 323: 970-975.
27. Simmons D, Kenealy T, Scott DJ. Implementing the South Auckland Diabetes Plan: barriers and lessons. N Z Med J 2000; 113: 364-366.
28. Simmons D, Fleming C, Cameron M, Leakehe L. A pilot diabetes awareness and exercise programme in a multiethnic workforce. N Z Med J 1996; 109: 373-376.
29. Wilson P, Simmons D. South Auckland Community Diabetes Planning Group. The development of community orientated recommendations for diabetes care in south Auckland. N Z Med J 1994; 107: 456-459.